Tofacitinib for chronic, refractory, moderate to severe alopecia areata. A retrospective review of 127 patients

被引：0
|
作者：
Photiou, L. [1 ,2 ,3 ]
Meah, N. [3 ]
Wall, D. [3 ]
Sinclair, R. [3 ,4 ,5 ]
机构：
[1] Alfred Hosp Melbourne, Victorian Melanoma Serv, Melbourne, Vic, Australia
[2] Skin & Canc Fdn, Melbourne, Vic, Australia
[3] Sinclair Dermatol, Dermatol & Clin Trials, Melbourne, Vic, Australia
[4] Univ Melbourne, Dermatol, Melbourne, Vic, Australia
[5] Epworth Med Fdn, Melbourne, Vic, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
    Park, Hyun-Sun
    Kim, Min-Woo
    Lee, Ji Su
    Yoon, Hyun-Sun
    Huh, Chang-Hun
    Kwon, Ohsang
    Cho, Soyun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) : 978 - 980
  • [2] Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients
    Mahajan, Rahul
    Mehta, Hitaishi
    De, Dipankar
    Handa, Sanjeev
    PEDIATRIC DERMATOLOGY, 2025,
  • [3] Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
    Zhang, Wenxin
    Li, Xiangqian
    Chen, Baifu
    Zhang, Jianzhong
    Torres-Culala, Kara Melissa T.
    Zhou, Cheng
    FRONTIERS IN MEDICINE, 2022, 9
  • [4] Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
    Numata, Takafumi
    Irisawa, Ryokichi
    Mori, Miho
    Uchiyama, Masaki
    Harada, Kazutoshi
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [5] Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
    Lee, Ji Su
    Huh, Chang-Hun
    Kwon, Ohsang
    Yoon, Hyun-Sun
    Cho, Soyun
    Park, Hyun-sun
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 819 - 822
  • [6] Effectiveness of oral tofacitinib treatment on patients with moderate-to-severe alopecia areata in Iran
    Asilian, Ali
    Mohammadian, Parisa
    Shahmoradi, Zabihollah
    JOURNAL OF COSMETIC DERMATOLOGY, 2024, 23 (03) : 886 - 890
  • [7] Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
    Moussa, Anthony
    Eisman, Samantha
    Kazmi, Ahmed
    Poa, Janina
    Chitreddy, Vijaya
    Rathnayake, Deepani
    Joseph, Shobha
    Sinclair, Rodney Daniel
    Bhoyrul, Bevin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1194 - 1196
  • [8] Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
    Liu, Lucy
    Craiglow, Brittany
    Dai, Feng
    King, Brett
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB261 - AB261
  • [9] Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
    Benton, Sarah
    Farah, Ronda
    Freese, Rebecca
    Hordinsky, Maria
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [10] Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
    Ibrahim, O.
    Hogan, S.
    Piliang, M.
    Bergfeld, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S65 - S65
12345